Treatment of Acute Non-Lymphocytic Leukemia with Conventional Induction, Consolidation Chemotherapy: Maintenance with Chemotherapy Versus Bone Marrow Transplantation Following Total Body Irradiation

Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328

KS Albain;JM Unger;JJ Crowley;CA Coltman;DL Hershman Journal of the National Cancer Institute 101(14):984-992

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systemic review and meta-analysis of prospective clinical trials [PMID9509382;PMC3163846]

J Koreth;R Schlenk;KJ Kopecky;S Honda;J Sierra;B Djulbegovic;M Wadleigh;DJ DeAngelo;RM Stone;H Sakamaki;FR Appelbaum;H Dohner;JH Antin;RJ Soiffer;C Cutler Journal of the American Medical Association 301(22)2349-2361

Minority report: how best to analyze clinical trial data to address disparities

D Hershman;J Unger Breast Cancer Research and Treatment 118:519-521

Long-term survival after chemotherapy for acute myeloid leukemia: The experience of the Southwest Oncology Group.

FR Appelbaum;KJ Kopecky Cancer 80:2199-2204

Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia.

D Head;KJ Kopecky;J Weick;JC Files;D Ryan;K Foucar;M Montiel;J Bickers;A Fishleder;M Miller;C Spier;C Hanson;M Bitter;R Braziel;G Mills;J Welborn;W Williams;J Hewlett;C Willman;FR Appelbaum Blood 86(5):1717-1728

A prospective evaluation of the roles of allogeneic marrow transplantation and low-dose monthly maintenance chemotherapy in the treatment of adult acute myelogenous leukemia (AML): A Southwest Oncology Group study

J Hewlett;KJ Kopecky;D Head;HJ Eyre;L Elias;L Kingsbury;SP Balcerzak;L Dabich;H Hynes;JN Bickers;FR Appelbaum Leukemia 9:562-569

Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience.

DR Head;KJ Kopecky;C Willman;FR Appelbaum Leukemia 8(Suppl.2):S38-S41

Reply to comments by Fenaux and Warrell.

DR Head;KJ Kopecky;C Willman;FR Appelbaum Leukemia 8(Suppl.2):S62

Background dysplasia in acute myeloblastic leukemia (AML).

D Head;K Kopecky;G Snow;FR Appelbaum;CL Willman U.S. Canadian Academy of Pathology Lab Investment 66:79A

Expression of the c-fgr and hck protein-tyrosine kinases in acute myeloid leukemic blasts is associated with early commitment and differentiation events in the monocytic and granulocytic lineages.

CL Willman;CC Stewart;TL Longacre;DR Head;R Habbersett;SF Zeigler;RM Perlmutter Blood 77(4):726-734

Survival with cytotoxic therapy in acute promyelocytic leukemia. A Southwest Oncology Group report.

DR Head;K Kopecky;J Hewlett;J Weick;D Ryan;J Files;J Bickers;K Foucar;M Montiel;A Fishleder;J Welborn;G Mills;E Billeter;C Willman;F Appelbaum Blood 78:268a

Significance of HLA-DR and FC receptor expression in acute non-lymphoblastic leukemia (ANLL).

L Elias;DE Van Epps;JS Hewlitt;FR Appelbaum;DP Head;KJ Kopecky;MR Grever ASCO 8:200(#776)

Prognostic factor analysis of the outcome of marrowtransplantation or further chemotherapy for acute nonlymphocyticleukemia.

RM Bukowski;J Montie;D Crawford ASCO 7:178(#689)

Prospective comparative study of bone marrow transplantation (BMT)versus continued chemotherapy for adult acute nonlymphocytic leukemia(ANL): A Southwest Oncology Group study.

FR Appelbaum;J Hewlett;K Kopecky;C Angle;C Coltman, Jr Presented ASH-December 1986